IRIS

Evaluation of the proportion of patients affected by subfoveal choroidal neovascularization secondary to age-related macular degeneration who are non-respondent to intravitreal ranibizumab injections (IVRI).

Non-Responders to Intravitreal Ranibizumab in Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration / Iacono, Pierluigi; Battaglia Parodi, Maurizio; Bandello, Francesco. - In: OPHTHALMIC RESEARCH. - ISSN 0030-3747. - 57:1(2017), pp. 42-47-47. [10.1159/000448955]

Non-Responders to Intravitreal Ranibizumab in Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Battaglia Parodi, Maurizio;Bandello, Francesco
2017-01-01

Abstract

Evaluation of the proportion of patients affected by subfoveal choroidal neovascularization secondary to age-related macular degeneration who are non-respondent to intravitreal ranibizumab injections (IVRI).
2017
Aged; Angiogenesis Inhibitors; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Intravitreal Injections; Macular Degeneration; Male; Prospective Studies; Ranibizumab; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/80539
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 4
social impact